HUTCHMED (China) Limited - ADR

HUTCHMED (China) Limited - ADR

HCM

Get informed when a big investor buys or sells

+ Follow
Market Cap$2.2B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
HUTCHMED (China) Limited - ADRHUTCHMED (China) Limited - ADR136.3-1%4.20.1
$13.80

Target Price by Analysts

9.2% upsideHUTCHMED (China) Limited Target Price DetailsTarget Price
$18.74

Current Fair Value

48.3% upside

Undervalued by 48.3% based on the discounted cash flow analysis.

Share Statistics

Market cap$2.20 Billion
Enterprise Value$2.19 Billion
Dividend Yield$- (-)
Earnings per Share$2.65
Beta0.43
Outstanding Shares173,168,080

Return

Return on Equity1.42%ROE
Return on Assets1.03%
Return on Invested Capital-2.38%

Valuation & Multiples

P/E Ratio136.31P/E Ratio
PEG-141.25PEG
Price to Sales4.21Price to Sales
Price to Book Ratio1.81Price to Book Ratio
Enterprise Value to Revenue3.99
Enterprise Value to EBIT-63.01
Enterprise Value to Net Income122
Total Debt to Enterprise0.04
Debt to Equity0.07Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
August 3, 2026
EPS Estimate
$0.15
Average shareholder expectation
Revenue Estimate
$306.40 M
Average shareholder expectation

Next Earnings Call

Expected Date
March 4, 2027
EPS Estimate
$0.21
Average shareholder expectation
Revenue Estimate
$329.08 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.00000%
Total Calls-
Total Puts-

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %2.49%▲ 2.23%
Total Invested$63.96M▼ 7.47%
Investors Holding53▲ 5.00%

ESG Score

No data

About Hutchison China Meditech Ltd.

CEO: Christian Hogg